Abstract
Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Current Bioactive Compounds
Title: Photosensitizer Nanoparticles for Photodynamic Therapy
Volume: 3 Issue: 4
Author(s): Toru Oba
Affiliation:
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Abstract: Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Export Options
About this article
Cite this article as:
Oba Toru, Photosensitizer Nanoparticles for Photodynamic Therapy, Current Bioactive Compounds 2007; 3 (4) . https://dx.doi.org/10.2174/157340707783220248
DOI https://dx.doi.org/10.2174/157340707783220248 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
Current Pharmaceutical Biotechnology Application and Interpretation of Genome-Wide Association (GWA) Studies for Informing Pharmacogenomic Research - Examples from the Field of Age-Related Macular Degeneration
Current Molecular Medicine Integrase Interactor 1 in Health and Disease
Current Protein & Peptide Science Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia
Current Molecular Medicine Role of Nuclear Steroid Receptors in Apoptosis
Current Medicinal Chemistry Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews Possible Role of DNA Methylation in the Induction of Systemic Lupus Erythematosus
Current Rheumatology Reviews Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Design and Development of Signal Transduction Inhibitors for Cancer Treatment: Experience and Challenges with Kinase Targets
Current Signal Transduction Therapy Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents
Anti-Cancer Agents in Medicinal Chemistry CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design Biologically Active Insulin-derived Peptides
Protein & Peptide Letters RNA Interference as Therapeutics for Hepatocellular Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Antiproliferative Effects of Molecular Iodine in Cancers
Current Chemical Biology Insertional Mutagenesis by Retroviral Vectors: Current Concepts and Methods of Analysis
Current Gene Therapy Transfection of CXCR-4 Using Microbubble-Mediated Ultrasound Irradiation and Liposomes Improves the Migratory Ability of Bone Marrow Stromal Cells
Current Gene Therapy Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview
Current Drug Targets